Search

Your search keyword '"Guallar, Víctor"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Guallar, Víctor" Remove constraint Author: "Guallar, Víctor"
144 results on '"Guallar, Víctor"'

Search Results

1. Scoreformer: A Surrogate Model For Large-Scale Prediction of Docking Scores

2. Optimizing Drug Design by Merging Generative AI With Active Learning Frameworks

3. Sub-micro- and nano-sized polyethylene terephthalate deconstruction with engineered protein nanopores

9. Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection

11. Detection of SARS-CoV-2 in a cat owned by a COVID-19–affected patient in Spain

12. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity

15. Genetically engineered proteins with two active sites for enhanced biocatalysis and synergistic chemo- and biocatalysis

17. Oxidoreductases on their way to industrial biotransformations

19. Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 and golden Syrian hamster upon SARS-CoV-2 infection.

23. EP-Pred: A Machine Learning Tool for Bioprospecting Promiscuous Ester Hydrolases

24. A Plurizyme with Transaminase and Hydrolase Activity Catalyzes Cascade Reactions

28. Metagenomic Mining for Esterases in the Microbial Community of Los Rueldos Acid Mine Drainage Formation

31. Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice

34. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes

36. Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice.

37. Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen

38. Piglets inoculated by different routes are not susceptible to SARS‐CoV‐2, but those inoculated parenterally were immunized against the virus

39. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in hamsters

40. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster

42. Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies

43. Detection of SARS-CoV-2 in a cat owned by a COVID-19−affected patient in Spain

45. Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect after a Drug Repurposing Screen

46. Genetically engineered proteins with two active sites for enhanced biocatalysis and synergistic chemo- and biocatalysis

48. Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies.

Catalog

Books, media, physical & digital resources